Zamora Rodríguez F J, Benítez Vega C, Sánchez-Waisen Hernández M R, Guisado Macías J A, Vaz Leal F J
Physician Specialist (F.E.A.) in Psychiatry, Equipo de Salud Mental de Zafra (Badajoz), Spain.
Midwife, Centro de Salud de Zafra (Badajoz), Spain.
Pharmacopsychiatry. 2017 Jan;50(1):38-40. doi: 10.1055/s-0042-110492. Epub 2016 Jul 14.
Paliperidone palmitate treatment of schizophrenia or schizoaffective disorder is effective and well tolerated, but there is almost no data on its safety during pregnancy. An analysis is made of the safety and tolerability of paliperidone palmitate treatment throughout the gestation period in a 34-year-old patient diagnosed with schizoaffective disorder. Paliperidone palmitate treatment throughout the gestation period was safe and well tolerated by both mother and foetus, there being no malformations or other perinatal complications in the newborn to date.
棕榈酸帕利哌酮治疗精神分裂症或分裂情感性障碍有效且耐受性良好，但几乎没有关于其在孕期安全性的数据。对一名34岁被诊断为分裂情感性障碍的患者在整个妊娠期使用棕榈酸帕利哌酮治疗的安全性和耐受性进行了分析。整个妊娠期使用棕榈酸帕利哌酮治疗对母亲和胎儿均安全且耐受性良好，迄今为止新生儿未出现畸形或其他围产期并发症。
